GARRONE, PAOLA MARIA OLGA
 Distribuzione geografica
Continente #
NA - Nord America 389
EU - Europa 101
AS - Asia 74
SA - Sud America 3
AF - Africa 1
Totale 568
Nazione #
US - Stati Uniti d'America 386
IT - Italia 48
SG - Singapore 36
SE - Svezia 33
IN - India 20
CN - Cina 7
DE - Germania 6
ID - Indonesia 6
CA - Canada 3
ES - Italia 3
GB - Regno Unito 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
IE - Irlanda 2
BR - Brasile 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
RU - Federazione Russa 1
UA - Ucraina 1
VA - Santa Sede (Città del Vaticano) 1
ZA - Sudafrica 1
Totale 568
Città #
Fairfield 75
Ashburn 30
Seattle 30
Woodbridge 30
Santa Clara 29
Singapore 29
Houston 24
Wilmington 21
Chandler 19
Rome 18
Cambridge 17
Princeton 13
Ann Arbor 11
San Paolo di Civitate 10
Jakarta 6
Millbury 6
Andover 5
Beijing 5
Boston 5
Lawrence 5
Berkley 4
Phoenix 4
Plano 4
San Diego 4
Alicante 3
Catania 2
Dublin 2
Federal 2
Milan 2
Ottawa 2
Sharjah 2
Silea 2
Tokyo 2
Venice 2
Dallas 1
Falkenstein 1
Frankfurt am Main 1
Jinan 1
Memphis 1
Montréal 1
Muizenberg 1
Nardò 1
Niterói 1
Norwalk 1
Oslo 1
Redmond 1
Salerno 1
San Mateo 1
Taidera 1
Totale 440
Nome #
Assessment of smart-meter-enabled dynamic pricing at utility and river basin scale 103
Determinants of the price response to residential water tariffs: meta-analysis and beyond 88
Barriers and drivers in the adoption of advanced wastewater treatment technologies: a comparative analysis of Italian utilities 75
Why do local governments resist contracting out? 62
Incentives to water conservation under scarcity: Comparing price and reward effects through stated preferences 59
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: An open-label, 2 × 2 factorial, randomised phase 3 trial 54
Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival a randomized clinical trial 54
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 54
Response of residential water demand to dynamic pricing: Evidence from an online experiment 39
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡ 14
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients. Results of the VICTOR-6 study 13
Totale 615
Categoria #
all - tutte 2.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202089 0 0 0 0 15 12 13 12 12 11 9 5
2020/2021100 3 4 1 3 1 0 0 5 14 61 6 2
2021/2022102 2 10 4 1 18 3 10 6 9 3 17 19
2022/202397 24 21 7 3 13 11 3 5 6 0 3 1
2023/202459 3 10 5 4 5 5 0 2 1 10 11 3
2024/202578 2 20 14 11 31 0 0 0 0 0 0 0
Totale 615